Skip to main content
SpringerLink
Log in

Organizational Problems, Costs, and Data Collection

  • Chapter
Treatment of Peritoneal Surface Malignancies

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 887 Accesses

Abstract

The combined procedure of cytoreductive surgery and chemohyperthermic intraperitoneal perfusion with antiblastic solutions (CRS plus HIPEC) is a promising approach to the treatment of peritoneal carcinomatosis (PC). Experienced surgical skills and multidisciplinary team working are required to perform this complex and integrated procedure in dedicated surgical oncology units of highly specialized centers. Ongoing and future studies will be able to suggest this as the next standard of care for many patients with PC. This promising landscape emphasizes the importance of standardizing procedures, providing adequate technology and treatment centers, and increasing surgeons’ learning curve and awareness of the results of this procedure. Common protocols are needed to ensure the maximum organizational efficiency and safety in the operating room (OR). Centers at which this type of treatment is performed began to elaborate personal protocols and opened the way to such work.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from non-ovarian origin by cytoreductive surgery combined with perioperative in-traperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608–5618

    Article  PubMed  Google Scholar 

  2. Deraco M, Kusamura S, Laterza B et al (2006) Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for the treatment of pseudomixoma peritonei: ten years experience in a single center. In Vivo 20:773–776

    CAS  PubMed  Google Scholar 

  3. Baratti D, Kusamura S, Nonaka D et al (2009) Pseudomixoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 249:243–249

    Article  PubMed  Google Scholar 

  4. Verwaal VJ, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743

    Article  PubMed  Google Scholar 

  5. Elias D, Lefevre JH, Chevalier J et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatino for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–685

    Article  PubMed  Google Scholar 

  6. Kusamura S, Baratti D, Hutanu I et al. (2012) The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs. Surg Oncol Clin N Am 21:559–576

    Article  PubMed  Google Scholar 

  7. Jacquet P, Sugarbaker PH (1996) Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15:49–58

    Google Scholar 

  8. Sugarbaker PH (1996) Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. In: Sugarbaker P, editor. Peritoneal carcinomatosis: drugs and diseases. Boston, Kluwer Academic Publishers, pp. 75–86

    Chapter  Google Scholar 

  9. Arienti C, Tesei A, Verdecchia GM et al (2013) Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. Clin Colorectal Cancer 12:122–127

    Article  CAS  PubMed  Google Scholar 

  10. Sumida M, Inaba H, Isawa E et al (1999) Prevention by Methylprednisolone of increased circulating tumor necrosis factor-α and lung injury associated with systemic infiammatory response syndrome due to intraperitoneal hyperthermia. Anesth Analg 88:771–776

    CAS  PubMed  Google Scholar 

  11. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 21:29–42

    Article  Google Scholar 

  12. Sugarbaker PH (1999) Management of peritoneal-surface malignancy: the surgeons role. Langenbecks Arch Surg 384:576–587

    Article  CAS  PubMed  Google Scholar 

  13. www.salute.gov.it

    Google Scholar 

  14. Glehen O, Cotte E, Kusamura S et al (2008) Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol 98:242–246

    Article  PubMed  Google Scholar 

  15. Vaira M, Barone R, Aghemo B et al (2001) Renal protection with amifostine during intraoperative peritoneal chemiohyperthermia with cisplatin (CDDP) for peritoneal carcinomatosis. Phase I trial. Minerva Med 92:207–211

    CAS  PubMed  Google Scholar 

  16. Elias D, Goere D, Blot F et al (2007) Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after complete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14:1818–1824

    Article  PubMed  Google Scholar 

  17. Stephens AD, Alderman R, Chang D et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–796

    Article  CAS  PubMed  Google Scholar 

  18. Stuart OA, Stephens AD, Welch L et al (2002) Safety monitoring of the Coliseum technique for heated intraoperative chemotherapy with mitomycin C. Ann Surg Oncol 9:186–191

    Article  PubMed  Google Scholar 

  19. Guerbet M, Goulle JP, Lubrano J (2007) Evaluation of the risk of contamination of surgical personnel by vaporization of Oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 33:623–626

    Article  CAS  PubMed  Google Scholar 

  20. Schmid K, Boettcher MI, Pelz JO et al (2006) Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with mitomycin C. Eur J Surg Oncol 32:1222–1225

    Article  CAS  PubMed  Google Scholar 

  21. Stuart OA, Stephens AD, Welch L et al (2002) Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mytomicin C. Ann Surg Oncol 9:186–191

    Article  PubMed  Google Scholar 

  22. Naslund Andreasson S, Anundi H, Thoren SB et al (2010) Is platinum present in the blood and urine from treatment givers during hypothermic intraperitoneal chemotherapy? J Oncol 2010:649–719

    Article  Google Scholar 

  23. Gonzales Moreno S, Gonzales Bayon L, Ortega Perez G (2012) Hyperthermic Intraperitoneal Chemotherapy. Methodology and safety considerations. Surg Oncol Clin N Am 21:543–557

    Article  Google Scholar 

  24. Baratti D, Scivales A, Balestra MR et al (2010) Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 36:463–469

    Article  CAS  PubMed  Google Scholar 

  25. Bonastre J, Jan P, de Pouvourville G et al (2005) Cost of an intraperitoneal hyperthermia related to cytoreductive surgery. Ann Chir 130:553–561

    Article  CAS  PubMed  Google Scholar 

  26. Chua TC, Martin S, Saxena A et al (2010) Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 251:323–329

    Article  PubMed  Google Scholar 

  27. Bristow RE, Santillan A, Diaz-Montes TP et al (2007) Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Cancer 109:1513–1522

    Article  PubMed  Google Scholar 

  28. Elias D, Goerè D, Dumont F et al (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastasis. Eur J Cancer 50:332–340

    Article  CAS  PubMed  Google Scholar 

  29. Kuijpers AMJ, Mirck B, Aalbers AGJ et al (2013) Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol 20:4224–4230

    Article  PubMed Central  PubMed  Google Scholar 

  30. Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from non-ovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608–5618

    Article  PubMed  Google Scholar 

  31. Elias D, Gilly F, Boutitie F et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68

    Article  PubMed  Google Scholar 

  32. Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesotelioma: multi-institutional experience. J Clin Oncol 27:6237–6242

    Article  PubMed  Google Scholar 

  33. Chua TC, Moran BJ, Sugarbaker PH et al (2012) Early- and long-term outcome data of patients with pseudomixoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456

    Article  PubMed  Google Scholar 

  34. Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608–5618

    Article  PubMed  Google Scholar 

  35. Deraco M, Kusamura S, Virzì S et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase II trial. Gynaecol Oncol 122:215–220

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Advanced Oncological Therapies, “G.B. Morgagni- L. Pierantoni” Hospital, Forlì, Italy

    Carlo Vallicelli

Authors
  1. Carlo Vallicelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simone Sibio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Cardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Davide Cavaliere
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giorgio Maria Verdecchia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlo Vallicelli .

Editor information

Editors and Affiliations

  1. Department of Surgery “Pietro Valdoni”, Sapienza University of Rome, Rome, Italy

    Angelo Di Giorgio

  2. Department of Medical, Surgical, and Neurological Sciences, University of Siena, Siena, Italy

    Enrico Pinto

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

Vallicelli, C., Sibio, S., Cardi, M., Cavaliere, D., Verdecchia, G.M. (2015). Organizational Problems, Costs, and Data Collection. In: Di Giorgio, A., Pinto, E. (eds) Treatment of Peritoneal Surface Malignancies. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5711-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5711-1_15

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5710-4

  • Online ISBN: 978-88-470-5711-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation